S Ura1, N Masuyama, J D Graves, Y Gotoh. 1. Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
Abstract
BACKGROUND: MST1 is an upstream kinase of the JNK and p38 MAPK pathways whose expression induces apoptotic morphological changes such as nuclear condensation. During apoptosis, caspase cleavage of MST1 removes a C-terminal regulatory domain, increasing the kinase activity of the MST1 N-terminal domain. Downstream pathways of MST1 in the induction of apoptosis remain to be clarified. RESULTS: In this study, we found that the expression of MST1 resulted in caspase-3 activation. Therefore, MST1 is not only a target of caspases but also an activator of caspases. This caspase activation and apoptotic changes occur through JNK, since the co-expression of a dominant-negative mutant of JNK inhibited MST1-induced morphological changes as well as caspase activation. In contrast, neither a dominant-negative p38 nor the p38 inhibitor SB203580 inhibited them. MST1 induced nucleosomal DNA fragmentation, which was suppressed by caspase inhibitors or ICAD (Inhibitor of Caspase-Activated DNase). Surprisingly, however, other changes such as membrane blebbing and chromatin condensation were not inhibited by caspase inhibitors. CONCLUSION: These results suggest that MST1 most likely promotes two events through JNK activation; first, MST1 induces the activation of caspases, resulting in CAD-mediated DNA fragmentation, and second, MST1 induces chromatin condensation and membrane blebbing without utilizing downstream caspases.
BACKGROUND:MST1 is an upstream kinase of the JNK and p38 MAPK pathways whose expression induces apoptotic morphological changes such as nuclear condensation. During apoptosis, caspase cleavage of MST1 removes a C-terminal regulatory domain, increasing the kinase activity of the MST1 N-terminal domain. Downstream pathways of MST1 in the induction of apoptosis remain to be clarified. RESULTS: In this study, we found that the expression of MST1 resulted in caspase-3 activation. Therefore, MST1 is not only a target of caspases but also an activator of caspases. This caspase activation and apoptotic changes occur through JNK, since the co-expression of a dominant-negative mutant of JNK inhibited MST1-induced morphological changes as well as caspase activation. In contrast, neither a dominant-negative p38 nor the p38 inhibitor SB203580 inhibited them. MST1 induced nucleosomal DNA fragmentation, which was suppressed by caspase inhibitors or ICAD (Inhibitor of Caspase-Activated DNase). Surprisingly, however, other changes such as membrane blebbing and chromatin condensation were not inhibited by caspase inhibitors. CONCLUSION: These results suggest that MST1 most likely promotes two events through JNK activation; first, MST1 induces the activation of caspases, resulting in CAD-mediated DNA fragmentation, and second, MST1 induces chromatin condensation and membrane blebbing without utilizing downstream caspases.
Authors: Bekir Cinar; Filiz Kisaayak Collak; Delia Lopez; Seckin Akgul; Nishit K Mukhopadhyay; Murat Kilicarslan; Daniel G Gioeli; Michael R Freeman Journal: Cancer Res Date: 2011-04-21 Impact factor: 12.701
Authors: Xuelai Luo; Zhaoming Li; Qun Yan; Xiaolan Li; Deding Tao; Jing Wang; Yan Leng; Kevin Gardner; Susan I V Judge; Qingdi Q Li; Junbo Hu; Jianping Gong Journal: Int J Mol Med Date: 2009-03 Impact factor: 4.101
Authors: Emilio Nogueira; Miguel Fidalgo; Arpad Molnar; John Kyriakis; Thomas Force; Juan Zalvide; Celia M Pombo Journal: J Biol Chem Date: 2008-03-25 Impact factor: 5.157
Authors: David Romano; David Matallanas; Gregory Weitsman; Christian Preisinger; Tony Ng; Walter Kolch Journal: Cancer Res Date: 2010-01-19 Impact factor: 12.701
Authors: Christopher J Record; Apirat Chaikuad; Peter Rellos; Sanjan Das; Ashley C W Pike; Oleg Fedorov; Brian D Marsden; Stefan Knapp; Wen Hwa Lee Journal: PLoS One Date: 2010-08-06 Impact factor: 3.240
Authors: Xiaolu Xu; Xinxin Wang; Elizabeth M Todd; Emily R Jaeger; Jennifer L Vella; Olivia L Mooren; Yunfeng Feng; Jiancheng Hu; John A Cooper; Sharon Celeste Morley; Yina H Huang Journal: J Immunol Date: 2016-07-27 Impact factor: 5.422